1. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy;Chung;Oncologist,2008
2. Infusion reactions: diagnosis, assessment, and management;Vogel;Clin J Oncol Nurs,2010
3. Management and preparedness for infusion and hypersensitivity reactions;Lenz;Oncologist,2007
4. World Health Organization. International drug monitoring: the role of national centres, report of a WHO meeting [held in Geneva from 20 to 25 September 1971], 1972.
5. Commissioner O of the. Reporting Serious Problems to FDA - What is a Serious Adverse Event? [Internet] (09 May 2017, date last accessed). http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm